Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

NCT06051240 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06051240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Lead sponsor
Region Stockholm
Phase
Phase 2
Overall status
Recruiting
Start date
February 16, 2024
Completion date
August 31, 2033
Enrollment
84 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, cognitive decline, cognitive impairment, late effect of radiation, memory impairment, radiotherapy side effect, radiotherapy; complications